Loading... (0%)
About liver disease
Genfit is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs...
Learn more
R&D Event Presentation
March 2016
Download
NASH: Optimizing therapy for progressive disease April 2016
Watch

Press releases
  • GENFIT: First quarter 2016 financial information
    04/26/2016
  • GENFIT announces enrollment of first patient in RESOLVE-IT, the pivotal Phase 3 clinical trial of Elafibranor in NASH
    03/10/2016
Events